Award

NIH Reporter #1R03CA307796-01

Enhancing perfusion-driven treatments with moderate dose radiotherapy in liver cancer

Recipient

Massachusetts General Hospital

Award Amount

$162,608.00

Ceiling

$162,608.00

Awarded

August 14, 2026

Identifier

1R03CA307796-01

NIH grant awarded to Massachusetts General Hospital to study the effects of moderate dose radiotherapy on blood perfusion in liver cancer, aiming to optimize combination therapies.

Description

This project aims to quantitatively study how ionizing radiation can induce a transitory enhancement of blood perfusion in hepatic tumors, to set the ground for synergistic combinations with perfusion-guided therapies. Animal experimentation will determine optimal radiation doses and timing for therapy strategies.

View original record